Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
Japan · Delayed Price · Currency is JPY 4,025.00
-23.00 (-0.57%)
Jul 30, 2025, 3:30 PM JST
Hisamitsu Pharmaceutical Co. Company Description
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan.
The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete′s foot; and ALLEGRA FX, a sinus medication for allergies.
It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders.
The company exports its products to Asia, the United States of America, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Hisamitsu Pharmaceutical Co., Inc.
| Country | Japan |
| Founded | 1847 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,799 |
| CEO | Kazuhide Nakatomi |
Contact Details
Address: Tashirodaikan-machi 408 Tosu, 841-0017 Japan | |
| Phone | 81 3 5293 1720 |
| Website | global.hisamitsu |
Stock Details
| Ticker Symbol | 4530 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | March - February |
| Reporting Currency | JPY |
| ISIN Number | JP3784600003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Kazuhide Nakatomi | Chief Executive Officer |